cesium chloride (CsCl)

11/01/2007 - "Three CsCl dose titration studies were completed in tumor-bearing and non-tumor-bearing athymic nude mice. "
01/01/2017 - "Taken together, our results suggest that these novel multifunctional, nucleus-targeting nanoparticles are a very promising in vivo gene delivery system capable of targeting CSCL and represent a new treatment candidate for improving the survival of cancer patients."
06/01/2015 - "Self-treatment of cancer with cesium chloride, despite proven lack of efficacy, continues to produce serious adverse effects. "
12/01/2013 - "CsCl is sold as an alternative treatment for cancer. "
12/01/2013 - "Fatal cesium chloride toxicity after alternative cancer treatment."

03/01/1993 - "The different doses of CsCl induced chromosomal aberrations in a dose-dependent manner. "
11/01/1991 - "CsCl induced chromosomal aberrations in frequencies directly proportional to the dose administered. "
06/01/1991 - "CsCl induced chromosomal aberration in frequencies directly proportional to the dose administered. "
10/01/1992 - "Both pretreatments significantly reduced the frequency of chromosome aberrations induced by CsCl given at three different doses, indicating that vitamin C, an essential component of P. "
06/01/1991 - "Simultaneous administration of chlorophyllin and CsCl reduced chromosomal aberrations significantly at 24 h. "

12/01/2004 - "Zero efficacy with cesium chloride self-treatment for brain cancer."
08/01/2004 - "We report acquired QT prolongation and sustained monomorphic ventricular tachycardia in a patient who self-initiated and completed a course of cesium chloride as adjunctive treatment for brain cancer."
08/01/2004 - "Acquired long QT syndrome and monomorphic ventricular tachycardia after alternative treatment with cesium chloride for brain cancer."
01/01/1984 - "The results showed that Cs+ possessed longer biological life time in the brain than Rb+ or Li+ which may be of therapeutic value, i.e., in the use of Cs salts in treatment of brain tumors and in conjunction with psychoactive agents provided the respective chemotherapeutic and antidepressant properties of CsCl have been established."

10/01/1985 - "The slope value of the linear regression line describing the relationship between pre-drive cycle length and pause duration for adenosine (15.8) was significantly greater than control (1.7), hypothermia (1.7), and cesium chloride (5.4). "
05/01/1992 - "Pretreatment with CsCl potentiated the 5-HT2-mediated head-twitches in the mouse but had no effects on hypothermia in the mouse induced by 8-OH-DPAT (0.5 mg/kg, s.c.). "
10/01/1985 - "In isolated perfused guinea pig hearts with surgically induced complete atrioventricular block, the effect of adenosine (2-20 microM) on pause duration was compared to two alternative means of slowing the pre-drive rate, i.e., hypothermia (28.0 degrees C to 34.0 degrees C) and cesium chloride (0.3-1.0 mM). "

01/01/2006 - "Diagnostic categories included: "normal gallbladder"; "uncomplicated symptomatic cholelithiasis" (uncomplicated SCL; stones present but symptoms and signs relieved and no abnormal blood-work); or "complicated symptomatic cholelithiasis" (CSCL; stones and positive symptoms and signs including abnormal blood-work). "